发明名称 |
STABLE LAQUINIMOD PREPARATIONS |
摘要 |
The subject invention provides a pharmaceutical composition comprising N-ethyl-N-phenyl-1,2,-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide or the salt thereof; a pharmaceutically acceptable carrier; and not more than 0.5% w/w relative to N-ethyl-N-phenyl-1,2,-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide of 2-Chloro-6-(1-ethyl- N -methyl-2-oxoindoline-3-carboxamido) benzoic acid, 1 H ,3 H -spiro[5-chloro-1-methylquinoline-2,4-dione-3,3'-[1]ethylindolin-[2]-one], or 5-Chloro- N -ethyl-3-hydroxy-1-methyl-2,4-dioxo- N -phenyl-1,2,3,4-tetrahydro-quinoline-3-carboxamide. |
申请公布号 |
EP2234485(B1) |
申请公布日期 |
2013.11.13 |
申请号 |
EP20080864658 |
申请日期 |
2008.12.19 |
申请人 |
TEVA PHARMACEUTICAL INDUSTRIES, LTD. |
发明人 |
SAFADI, MUHAMMAD;LICHT, DANIELLA;LOVINGER, IOANA;EYAL, AHARON, M.;FRISTEDT, TOMAS;JANSSON, KARL |
分类号 |
A61K9/16;A61K9/20;A61K31/438;A61K31/4704;C07D209/34;C07D209/42;C07D471/10 |
主分类号 |
A61K9/16 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|